| α-12G | Dodecagalloyl |
| AKT | AKT serine–threonine protein kinase |
| ASD | Autism spectrum disorder |
| CSF | Cerebrospinal fluid |
| DAAO | D-amino acid oxidase |
| DASPO;DDO | D-aspartate oxidase |
| DISC1 | Disrupted-in-schizophrenia 1 |
| GABA | γ-aminobutyric acid |
| GAMs | Generalized additive models |
| H2S | Hydrogen sulfide |
| HAMD17 | 17-Item Hamilton Depression Rating Scale |
| IML | Interpretable machine learning |
| 5-HT | 5-Hydroxytryptamine, serotonin |
| Lasso | Least absolute shrinkage and selection operator |
| LTP | Long-term potentiation |
| MARCKS | Myristoylated alanine rich protein kinase C |
| MCP | Mercaptopyruvate |
| MK-801 | Dizocilpine |
| NMDA | N-Methyl-D-aspartate |
| NMDAR | N-Methyl-D-aspartate glutamate receptor |
| NPCs | Neural progenitor cells |
| OCF | Overall cognitive function |
| PANSS | Positive and Negative Syndrome Scale |
| PCP | Phencyclidine |
| PFC | Prefrontal cortex |
| PPI | Prepulse inhibition |
| QLS | Quality of Life Scale |
| ROC | Receiver Operating Characteristic |
| SANS | Scale for Assessment of Negative Symptoms |
| SR | Serine racemase |
| SNPs | Single nucleotide polymorphisms |
| TRS | Treatment-resistant schizophrenia |